IMMUCELL CORP /DE/
جودة البيانات: 100%
ICCC
Nasdaq
Manufacturing
Chemicals
KWD 7.08
▼
KWD 0.11
(-1.53%)
القيمة السوقية: 65.05 M
السعر
KWD 7.19
القيمة السوقية
65.05 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—
Quick Summary
النقاط الرئيسية
Debt/Equity of 0.32 — conservative balance sheet
Generating 1.22 M in free cash flow
Capital efficient — spends only 4.52% of revenue on capex
ROIC of 3.10% — low return on invested capital
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)4.34%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-3.49%
أعلى من متوسط القطاع (-53.53%)
ROIC3.10%
Net Margin-3.76%
Op. Margin5.97%
الأمان
Debt / Equity
0.32
أعلى من متوسط القطاع (0.31)
Current Ratio4.21
Interest Coverage3.34
التقييم
PE (TTM)
-62.54
أقل من متوسط القطاع (-1.48)
P/B Ratio2.18
EV/EBITDA15.94
Dividend YieldN/A
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1366 نظير)
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1366 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -62.5 | -1.5 |
| P/B | 2.2 | 1.6 |
| ROE % | -3.5 | -53.5 |
| Net Margin % | -3.8 | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | 0.3 | 0.3 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
لا تتوفر تقديرات مستقبلية
No quarterly estimates available
مفاجآت الأرباح
آخر 4 أرباع
| الربع | EPS المقدر | EPS الفعلي | المفاجأة |
|---|---|---|---|
| Q42020 | -KWD 0.04 | KWD 0.03 | +175.0% |
| Q32020 | -KWD 0.08 | -KWD 0.04 | +50.0% |
| Q22020 | -KWD 0.10 | -KWD 0.11 | -10.0% |
| Q12020 | N/A | -KWD 0.02 | — |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.34% | Revenue Growth (3Y) | 25.79% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 27.64 M | Net Income (TTM) | -1.04 M |
| ROE | -3.49% | ROA | -2.25% |
| Gross Margin | 41.40% | Operating Margin | 5.97% |
| Net Margin | -3.76% | Free Cash Flow (TTM) | 1.22 M |
| ROIC | 3.10% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.32 | Current Ratio | 4.21 |
| Interest Coverage | 3.34 | Asset Turnover | 0.60 |
| Working Capital | 12.83 M | Tangible Book Value | 29.70 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -62.54 | Forward P/E | N/A |
| P/B Ratio | 2.18 | P/S Ratio | 2.35 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 15.94 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 1.88% | ||
| Market Cap | 65.05 M | Enterprise Value | 70.65 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.12 | Revenue / Share | 3.06 |
| FCF / Share | 0.14 | OCF / Share | 0.27 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 4.52% | FCF Conversion | -117.77% |
| SBC-Adj. FCF | 955,206 | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 27.64 M | 26.49 M | 17.47 M | — | — |
| Net Income | -1.04 M | -2.16 M | -5.77 M | -2.49 M | -78,292.0 |
| EPS (Diluted) | -0.12 | -0.26 | -0.75 | -0.32 | -0.01 |
| Gross Profit | 11.45 M | 7.94 M | 3.87 M | 7.65 M | 8.66 M |
| Operating Income | 1.65 M | -1.64 M | -5.75 M | -2.30 M | 257,385.0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 3.04 M | 3.90 M | 4.39 M | 4.49 M | 4.17 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 2.78 M | — | — | — | — |
| Interest Expense | 493,384.0 | — | 475,598.0 | 348,536.0 | — |
| Income Tax | 11,570.0 | 10,056.0 | 4,627.0 | 7,672.0 | 9,165.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 42.53 M | 45.10 M | 43.81 M | 44.86 M | 44.47 M |
| Total Liabilities | 15.48 M | 17.58 M | 18.82 M | 14.48 M | 11.89 M |
| Shareholders' Equity | 27.06 M | 27.52 M | 24.99 M | 30.38 M | 32.58 M |
| Total Debt | 9.10 M | — | 10.43 M | 10.23 M | 812,207.0 |
| Cash & Equivalents | 3.81 M | — | 978,741.0 | 5.79 M | 10.19 M |
| Current Assets | 16.94 M | 15.04 M | — | 13.99 M | 16.26 M |
| Current Liabilities | 3.98 M | 4.41 M | 4.20 M | 3.07 M | 2.53 M |
{"event":"ticker_viewed","properties":{"ticker":"ICCC","listing_kind":"stock","pathname":"/stocks/iccc","exchange":"Nasdaq","country":"US"}}